
To identify the top managed care pharmacy challenges and what your peers are doing about them, Managed Healthcare Executive conducted its annual pharmacy survey during the first quarter of 2017.

To identify the top managed care pharmacy challenges and what your peers are doing about them, Managed Healthcare Executive conducted its annual pharmacy survey during the first quarter of 2017.

One expert believes managed care executives are key to a necessary paradigm shift in pediatric polypharmacy.

Here’s how to overcome the hurdles that hinder your population health strategies.

Alhough interest in value-based compensation for physicians continues to rise, trying to implement new payment systems is complex. Here's how to do it.

A new Kaiser poll has surprising results and three important findings.

Trump’s proposal highlights the administration’s priorities and can give stakeholders insight into future policy change.

Artificial intelligence will play a major role in healthcare digital transformation. Here’s how to adopt more AI-supported activities in your digital transformation initiative.

The first generic Truvada for treating and preventing HIV will be available, but when?

FDA approves Isentress at a higher dose for HIV-1 infected patients.

An annual study commissioned by Quest Diagnostics and Inovalon reveals interesting findings to keep value-based care moving forward.

The conference raised important points about unregulated growth opportunities and new pharmacy arena players.

A Klick Health survey shows there’s opportunities for healthcare innovation and technology to play larger role in patient’s lives.

A new trial for AstraZeneca’s benralizumab shows promising results for severe asthma patients.

WalletHub released a study comparing 50 states and the District in terms of 15 key metrics, ranging from arrest and overdose rates to opioid prescriptions and meth-lab incidents per capita.

FDA has approved the first generic versions of Strattera (atomoxetine) for the treatment of attention deficit/hyperactivity disorder.

HealthPartners aims to improve price information for consumers. Here’s how.

Although drug spend is increasing for inflammatory conditions, diabetes, and oncology, there are some promising developments in the pipeline.

MCOs are fighting back against rising pharmaceutical costs. Here are the top strategies they are embracing.

Alternatives to opioids programs emerge as viable tools to mitigate the crisis.

AHIP 2017: SummaCare exec shares their best practices for patient care outreach.

Are you making any of these mistakes? Here are the biggest pitfalls healthcare industry leaders say you should avoid.

AHIP 2017 presentation: The spirit of accountable care keeps providers’ focus on data-driven clinical solutions.

Oak Street Health co-founder tells AHIP 2017 attendees about its novel approach to patient care.

AHIP 2017: Kaveh Savafi, MD, of Accenture, tells Managed Healthcare Executive about the biggest digital trends and their impact on healthcare.

A new RAND analysis of retail clinics finds they could be increasing healthcare costs.

Digital health pioneer Eric Topol talks about plans for a four-year precision medicine study at AHIP 2017.

AHIP 2017: Older adults with complex chronic conditions require payers to “look under the hood.”

Lilly's galcanezumab proves successful in three phase 3 migraine studies. Here are the findings.

AstraZeneca voluntarily recalls professional samples of its antiplatelet agent. Here's what to do.

The days of the traditional, channel-focused and largely enshrouded PBM business model have come and gone. Here’s what’s next.